Vir Biotechnology VIR
NASDAQ VIR
$10.57 -0.17 (-1.58%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) EV to EBITDA (2021 - 2022)

Updated

Vir Biotechnology's EV to EBITDA came in at 1.19 for Q4 2022, down 89.7% from 11.55 a year earlier but up 672.4% from the prior quarter.

Analysis

Vir Biotechnology (VIR) EV to EBITDA (2021 - 2022) Analysis & Trends

Going back to Q4 2021, Vir Biotechnology's EV to EBITDA data covers 5 quarters.

  • Going back by year, EV to EBITDA was 11.55 in FY2021.
  • The five-year range for quarterly EV to EBITDA is 0.15 (Q3 2022) to 11.55 (Q4 2021).
  • Business Quant data shows VIR's EV to EBITDA at 0.15 (Q3 2022), 0.93 (Q2 2022) and 1.37 (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Vir Biotechnology 1.77 Bn -185.85 Mn 238.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.19
Sep 30, 2022 0.15
Jun 30, 2022 0.93
Mar 31, 2022 1.37
Dec 31, 2021 11.55
API Access

Vir Biotechnology EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=VIR&period=max&api_key=YOUR_API_KEY